RNA Analytical/Quality Videos

1. Master Your mRNA Manufacturing 3/4/2025

   Join pDNA and mRNA specialists as they discuss innovative mRNA manufacturing solutions for your purification challenges, mRNA stability, and overall product quality.

2. A Novel Nuclease For CRISPR-Based Cell And Gene Therapies 10/28/2024

   Take an exploration of the therapeutic potential of hfCas12Max, showcasing its advantages over existing CRISPR nucleases and its role in accelerating the development of life-saving treatments.

3. Connecting Oligonucleotide R&D With Early Clinical Scale Manufacturing 10/27/2026

   Watch the webinar for practical considerations that can support a smoother transition from oligonucleotide R&D to early clinical-scale manufacturing.

4. Don't Forget These Important Points When Selecting An RNA CDMO 8/22/2024

   Together, Omega’s Jeff Atkinson & Sail Biomedicines’ Jim Nolan share their perspectives on the health of the linear mRNA and circRNA outsourcing sector.

5. Advancements In LNP CMC: What Are The Current "Known Knowns"? 12/4/2024

   In this Advancing RNA Live clip, Sanofi’s Sumit Luthra highlights the learnings we’ve made to-date about how our processes — both in terms of unit operations and process conditions — inform our LNP composition/heterogeneity.

6. A Wishlist For The Future: The Next Frontier Of The mRNA & Oligo Supply Chains 12/3/2025

   Here, Advancing RNA Live speakers Khaled Yamout, Sanofi’s Francoise Ribes, and Camp4’s Satya Kuchimanchi share which supply chain advancements they would like to see in the near future, as well as how they anticipate these changes & evolutions could impact each modality’s growth.

7. Which mRNA-LNP Attributes Deserve Deeper Characterization Today? 6/9/2026

   This Advancing RNA Live panel comprising Elaine Peters, Ilya Shestopalov, and Philippe Talaga addresses which mRNA-LNP attributes could benefit the most from orthogonal extended characterization.   

8. Establishing Analytical Methods For Emerging mRNA-Based Therapies 6/5/2023

   Here, we describe the use of cutting-edge technologies to assess critical quality attributes of both mRNA drug substances and drug products.

9. Optimal Tech For Predicting Drug Responses At The Cellular Level 4/1/2025

   Explore how preserving spatial molecular information and leveraging AI-driven spatial-omics can transform treatment prediction, patient stratification, and personalized medicine.

10. Determining Fragment Length for Enzymatic Ligation of gRNA 4/29/2026

    Advancing RNA Live panelists Max De Long, Venkat Krishnamurthy and April Sena address two audience questions about the number/length of fragments for enzymatic ligation of gRNA.